PHVS416 for HAE: First Patient Dosed in RAPIDe-1 Trial
Patients with hereditary angioedema (HAE) experience recurrent "attacks," or periods of swelling under the skin. Now, in a Phase 2 clinical trial, researchers are evaluating PHVS416 for patients with…